Piperazine, piperidine and 1,2,5,6-tetrahydropyridine
US5684020A · kind A · utility
19Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 1997 |
| Grant date | Nov 4, 1997 |
| Priority date | — |
| Expiry date | Jan 30, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound selected from those of formula: ##STR1## wherein: A-B, n, D and E are as defined in the specification, PA1 their racemic mixtures, and their optical isomers, PA1 and also the physiologically tolerable salts thereof with appropriate acids. The products of the invention may be used therapeutically.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.